Through nifty marketing and an insurance-circumventing subscription model that delivers medicine directly to your front door, ...

NVO advances obesity pipeline with CagriSema and Amycretin while expanding through major deals amid rising competition.

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Use of the weight-loss drug is rising among adolescents, but questions remain over long-term safety, access, and ...

Bloomberg: Michigan’s Largest Insurer To Drop Coverage For Obesity Drugs Like Wegovy Weight-loss drugs from Novo Nordisk A/S and Eli Lilly & Co. will lose coverage under many plans run by Michigan’s ...

More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right ...

Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...

American teens are increasingly turning to the weight-loss drug Wegovy, as more families and their doctors gain confidence in ...

New prescriptions for Wegovy among teenagers increased by 50% between 2023 and 2024, according to a June 3 report from healthcare data company Truveta. To analyze GLP-1 utilization trends among ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...